Review article · 2023

Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs

Mohamed T. Elsebay, Noura G. Eissa, Gehan Fathy Balata, Mohammad Amjad Kamal, Hanan M. El-Nahas

Current Pharmaceutical Design, 29(29), 2297–2312 · Published 1 August 2023 · DOI 10.2174/1381612829666230911105922

View at the publisherCite this paper

In brief

“Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs” is a 2023 review article by Mohamed T. Elsebay and 4 co-authors, published in Current Pharmaceutical Design. OpenAlex counts 15 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
15
Most cited in
2025 (7)
Field-weighted impact
0.29
References
143
Authors
5

Abstract

The poor water solubility of numerous novel drug candidates presents significant challenges, particularly in terms of oral administration. This limitation can result in various undesirable clinical implications, such as inter-patient variability, poor bioavailability, difficulties in achieving a safe therapeutic index, increased costs, and potential risks of toxicity or inefficacy. Biopharmaceutics Classification System (BCS) class II… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Elsebay, M. T., Eissa, N. G., Balata, G. F., Kamal, M. A., & El-Nahas, H. M. (2023). Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs. Current Pharmaceutical Design, 29(29), 2297–2312. https://doi.org/10.2174/1381612829666230911105922

MLA 9

Elsebay, Mohamed T., et al. “Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs.” Current Pharmaceutical Design, vol. 29, no. 29, 2023, pp. 2297–2312. https://doi.org/10.2174/1381612829666230911105922.

Chicago

Elsebay, Mohamed T., Noura G. Eissa, Gehan Fathy Balata, Mohammad Amjad Kamal, and Hanan M. El-Nahas. 2023. “Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs.” Current Pharmaceutical Design 29 (29): 2297–2312. https://doi.org/10.2174/1381612829666230911105922.

Harvard

Elsebay, M. T. et al. (2023) ‘Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs’, Current Pharmaceutical Design, 29(29), pp. 2297–2312. doi:10.2174/1381612829666230911105922.

IEEE

M. T. Elsebay, N. G. Eissa, G. F. Balata, M. A. Kamal, and H. M. El-Nahas, “Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs,” Current Pharmaceutical Design, vol. 29, no. 29, pp. 2297–2312, 2023, doi: 10.2174/1381612829666230911105922.

BibTeX

@article{elsebay2023nanosuspension,
  title     = {{Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs}},
  author    = {Elsebay, Mohamed T. and Eissa, Noura G. and Balata, Gehan Fathy and Kamal, Mohammad Amjad and El-Nahas, Hanan M.},
  journal   = {Current Pharmaceutical Design},
  year      = {2023},
  volume    = {29},
  number    = {29},
  pages     = {2297--2312},
  doi       = {10.2174/1381612829666230911105922},
  url       = {https://doi.org/10.2174/1381612829666230911105922}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202411
202577
202677

Its field-weighted citation impact is 0.29: it has been cited 0.29 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems

  • nanoparticle suspensions
  • poorly water-soluble drugs
  • drug solubility enhancement
  • bioavailability
  • oral drug delivery
  • parenteral drug delivery
  • Biopharmaceutics Classification System class II
  • stabilizers

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Elsebay, M. T., Eissa, N. G., Balata, G. F., Kamal, M. A., & El-Nahas, H. M. (2023). Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs. Current Pharmaceutical Design, 29(29), 2297–2312. https://doi.org/10.2174/1381612829666230911105922

How many times has this paper been cited?

15 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Mohamed T. Elsebay, Noura G. Eissa, Gehan Fathy Balata, Mohammad Amjad Kamal, Hanan M. El-Nahas.

What is the DOI of this paper?

10.2174/1381612829666230911105922. The permanent link is https://doi.org/10.2174/1381612829666230911105922.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.